Who
Andrew Schwendenman
Chief Accounting Officer
Company insider
Files Form 4 as: Chief Accounting Officer, Replimune Group.
In numbers
- Trades disclosed
- 15
- Buys
- 0
- Sells
- 4
- Bought
- $0
- Sold
- $320K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 1 Apr 2024
- Last trade
- 10 Aug 2026
- Last filed
- 12 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Aug 2026filed 12 Aug 2026 | REPL Replimune GroupBiotechnology | SEC FORM 4 Sold | $99K7,632 at $12.97 | filing |
| 10 Aug 2026filed 12 Aug 2026 | REPL Replimune GroupBiotechnology | SEC FORM 4 Sold | $99K7,632 at $12.97 | filing |
| 18 May 2026filed 20 May 2026 | REPL Replimune GroupBiotechnology | SEC FORM 4 Sold | $40K7,894 at $5.08 | filing |
| 18 May 2026filed 20 May 2026 | REPL Replimune GroupBiotechnology | SEC FORM 4 Sold | $40K7,894 at $5.08 | filing |
| 1 Apr 2026filed 7 Apr 2026 | REPL Replimune GroupBiotechnology | SEC FORM 4 Code A | —36,667 at $0.00 | filing |
| 1 Apr 2026filed 7 Apr 2026 | REPL Replimune Groupoption or derivative · Biotechnology | SEC FORM 4 Code A | —55,000 at $0.00 | filing |
| 1 Apr 2026filed 7 Apr 2026 | REPL Replimune Groupoption or derivative · Biotechnology | SEC FORM 4 Code A | —55,000 at $0.00 | filing |
| 1 Apr 2026filed 7 Apr 2026 | REPL Replimune GroupBiotechnology | SEC FORM 4 Code A | —36,667 at $0.00 | filing |
| 19 Dec 2025filed 19 Dec 2025 | REPL Replimune GroupBiotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 20 May 2025filed 22 May 2025 | REPL Replimune GroupBiotechnology | SEC FORM 4 Sold | $26K3,287 at $8.05 | filing |
| 1 Apr 2025filed 3 Apr 2025 | REPL Replimune Groupoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 1 Apr 2025filed 3 Apr 2025 | REPL Replimune GroupBiotechnology | SEC FORM 4 Code A | —33,333 at $0.00 | filing |
| 16 May 2024filed 20 May 2024 | REPL Replimune GroupBiotechnology | SEC FORM 4 Sold | $15K2,298 at $6.47 | filing |
| 1 Apr 2024filed 3 Apr 2024 | REPL Replimune Groupoption or derivative · Biotechnology | SEC FORM 4 Code A | —53,325 at $0.00 | filing |
| 1 Apr 2024filed 3 Apr 2024 | REPL Replimune GroupBiotechnology | SEC FORM 4 Code A | —17,775 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.